Svatek R - Search Results

1

Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.

Abdel-Aziz KF, Anderson JK, Svatek R, Margulis V, Sagalowsky AI, Cadeddu JA. Abdel-Aziz KF, et al. Among authors: svatek r. J Endourol. 2006 Sep;20(9):627-31. doi: 10.1089/end.2006.20.627. J Endourol. 2006. PMID: 16999613

2

Application of novel hemostatic agent during laparoscopic partial nephrectomy.

Margulis V, Matsumoto ED, Svatek R, Kabbani W, Cadeddu JA, Lotan Y. Margulis V, et al. Among authors: svatek r. J Urol. 2005 Aug;174(2):761-4. doi: 10.1097/01.ju.0000164727.53999.fe. J Urol. 2005. PMID: 16006972

3

Serum laboratory values following uncomplicated laparoscopic urological surgery.

Anderson JK, Matsumoto ED, Abdel-Aziz K, Svatek R, Cadeddu JA. Anderson JK, et al. Among authors: svatek r. J Urol. 2006 Jan;175(1):167-9. doi: 10.1016/S0022-5347(05)00045-5. J Urol. 2006. PMID: 16406899

4

Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.

Svatek RS, Sims R, Anderson JK, Abdel-Aziz K, Cadeddu JA. Svatek RS, et al. Urology. 2006 Mar;67(3):508-12. doi: 10.1016/j.urology.2005.09.046. Epub 2006 Feb 28. Urology. 2006. PMID: 16504265

5

Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.

Svatek RS, Herman MP, Lotan Y, Casella R, Hsieh JT, Sagalowsky AI, Shariat SF. Svatek RS, et al. Cancer. 2006 Apr 15;106(8):1701-7. doi: 10.1002/cncr.21795. Cancer. 2006. PMID: 16541433 Free article.

6

Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis.

Svatek RS, Sagalowsky AI, Lotan Y. Svatek RS, et al. Urol Oncol. 2006 Jul-Aug;24(4):338-43. doi: 10.1016/j.urolonc.2005.11.025. Urol Oncol. 2006. PMID: 16818188

7

Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.

Lotan Y, Svatek RS, Sagalowsky AI. Lotan Y, et al. Cancer. 2006 Sep 1;107(5):982-90. doi: 10.1002/cncr.22084. Cancer. 2006. PMID: 16862567 Free article.

8

The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.

Svatek RS, Lotan Y, Herman MP, Duchene DA, Sagalowsky AI, Cadeddu JA. Svatek RS, et al. J Urol. 2006 Oct;176(4 Pt 1):1321-5; discussion 125. doi: 10.1016/j.juro.2006.06.008. J Urol. 2006. PMID: 16952621

9

Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens.

Svatek RS, Karam JA, Rogers TE, Shulman MJ, Margulis V, Benaim EA. Svatek RS, et al. Prostate Cancer Prostatic Dis. 2007;10(3):279-82. doi: 10.1038/sj.pcan.4500954. Epub 2007 Feb 27. Prostate Cancer Prostatic Dis. 2007. PMID: 17325718 Clinical Trial.

10

Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours.

Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA. Stern JM, et al. Among authors: svatek r. BJU Int. 2007 Aug;100(2):287-90. doi: 10.1111/j.1464-410X.2007.06937.x. BJU Int. 2007. PMID: 17617136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters